| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 2.812.941.930 $ | 100,01 | 45.996.341 | ||||||
| CORCEPT THERAPEUTICS INC | CORCEPT THERAPEUTICS INC COM | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 157.460.972 $ | 5,60 | 1.810.937 | |
| NEOGENOMICS INC | NEOGENOMICS INC COM NEW | EC | 64049M209 | Long | Börsenkurs (Stufe 1) | 143.995.947 $ | 5,12 | 9.869.496 | |
| VERACYTE INC | VERACYTE INC COM | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 143.370.795 $ | 5,10 | 2.441.185 | |
| BRUKER CORP | BRUKER CORP COM | EC | 116794108 | Long | Börsenkurs (Stufe 1) | 121.506.850 $ | 4,32 | 2.019.057 | |
| ALKERMES PLC | ALKERMES PLC SHS | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 119.202.502 $ | 4,24 | 2.275.074 | |
| ILLUMINA INC | ILLUMINA INC COM | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 110.351.787 $ | 3,92 | 627.605 | |
| KRYSTAL BIOTECH INC | KRYSTAL BIOTECH INC COM | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 108.912.690 $ | 3,87 | 293.036 | |
| NATERA INC | NATERA INC COM | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 106.730.068 $ | 3,79 | 393.185 | |
| AXSOME THERAPEUTICS INC | AXSOME THERAPEUTICS INC COM | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 104.301.882 $ | 3,71 | 426.122 | |
| NEUROCRINE BIOSCIENCES INC | NEUROCRINE BIOSCIENCES INC COM | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 99.241.329 $ | 3,53 | 588.847 | |
| BIO-TECHNE CORP | BIO-TECHNE CORP COM | EC | 09073M104 | Long | Börsenkurs (Stufe 1) | 96.544.497 $ | 3,43 | 1.366.518 | |
| ARROWHEAD PHARMACEUTICALS INC | ARROWHEAD PHARMACEUTICALS INC COM | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 94.969.502 $ | 3,38 | 1.165.127 | |
| BIOGEN INC | BIOGEN INC COM | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 94.803.671 $ | 3,37 | 438.784 | |
| EXELIXIS INC | EXELIXIS INC COM | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 93.280.504 $ | 3,32 | 1.714.400 | |
| INCYTE CORP | INCYTE CORP COM | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 89.555.874 $ | 3,18 | 790.013 | |
| ARGENX SE | ARGENX SE SPONSORED ADR | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 88.057.434 $ | 3,13 | 94.913 | |
| HALOZYME THERAPEUTICS INC | HALOZYME THERAPEUTICS INC COM | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 87.590.861 $ | 3,11 | 1.119.086 | |
| VERTEX PHARMACEUTICALS INC | VERTEX PHARMACEUTICALS INC COM | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 86.415.125 $ | 3,07 | 173.968 | |
| REPLIGEN CORP | REPLIGEN CORP COM | EC | 759916109 | Long | Börsenkurs (Stufe 1) | 86.222.303 $ | 3,07 | 631.943 | |
| BIOMARIN PHARMACEUTICAL INC | BIOMARIN PHARMACEUTICAL INC COM | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 79.640.513 $ | 2,83 | 1.391.830 | |
| AMGEN INC | AMGEN INC COM | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 78.300.121 $ | 2,78 | 216.227 | |
| BIONTECH SE | BIONTECH SE SPONSORED ADS | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 73.949.347 $ | 2,63 | 794.727 | |
| GENMAB A/S | GENMAB A/S SPONSORED ADS | EC | 372303206 | Long | Börsenkurs (Stufe 1) | 73.800.902 $ | 2,62 | 2.686.600 | |
| UNITED THERAPEUTICS CORP | UNITED THERAPEUTICS CORP COM | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 71.926.849 $ | 2,56 | 132.748 | |
| ALNYLAM PHARMACEUTICALS INC | ALNYLAM PHARMACEUTICALS INC COM | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 70.923.270 $ | 2,52 | 235.602 | |
| BEONE MEDICINES LTD | BEONE MEDICINES LTD SPONSORED ADS | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 69.844.722 $ | 2,48 | 245.095 | |
| GILEAD SCIENCES INC | GILEAD SCIENCES INC COM | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 68.968.880 $ | 2,45 | 545.899 | |
| ADMA BIOLOGICS INC | ADMA BIOLOGICS INC COM | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 65.483.256 $ | 2,33 | 7.823.567 | |
| SAREPTA THERAPEUTICS INC | SAREPTA THERAPEUTICS INC COM | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 64.393.698 $ | 2,29 | 3.583.400 | |
| REGENERON PHARMACEUTICALS INC | REGENERON PHARMACEUTICALS INC COM | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 63.195.779 $ | 2,25 | 101.350 | |
| Gesamt | 2.812.941.930 $ | 100,01 | 45.996.341 |